Showing 1 - 20 results of 31 for search 'A. N. USKOV', query time: 0.04s
Refine Results
-
1
Chronic course of Ixodes tick borreliosis in Krasnoyarsk region by N. S. Minoranskaya, A. N. Uskov, E. I. Minoranskaya
Published 2014-09-01
Article -
2
Importance of immune status for prognosis chronic borreliosis infections by N. S. Minoranskaya, A. N. Uskov, P. V. Sarap
Published 2014-09-01
Article -
3
Clinical case of Ixodes-borne borreliosis an erythema form in combination with oncologic disease by A. N. Uskov, V. F. Krumgoltz, M. V. Yaremenko
Published 2014-09-01
Article -
4
-
5
ROTAVIRUS INFECTION IN CHILDREN IN THE RF: DIAGNOSTIC AND TREATMENT CHALLENGES TODAY by M. K. BECHTEREVA, A. M. KOMAROVA, A. N. USKOV
Published 2017-05-01
Article -
6
To the 70th anniversary of the Department of Infectious Diseases in Children by N. V. Skripchenko, A. N. Uskov, Yu. V. Lobzin
Published 2022-11-01
Article -
7
Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia by A. V. Rudakova, A. N. Uskov, S. M. Kharit, S. V. Sidorenko
Published 2014-09-01
Article -
8
-
9
Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1) by A. V. Rudakova, D. A. Gusev, A. N. Uskov, Yu. V. Lobzin
Published 2016-02-01
Article -
10
Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness by A. V. Rudakova, D. A. Gusev, A. N. Uskov, Yu. V. Lobzin
Published 2015-04-01
Article -
11
Cost-effectiveness of quadrivalent human papillomavirus vaccination in adolescent girls by A. V. Rudakova, S. M. Kharit, A. S. Lisianskaya, A. N. Uskov, Yu. V. Lobzin
Published 2016-11-01
Article -
12
-
13
The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines by S. M. Kharit, A. M. Rudakova, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2017-06-01
Article -
14
Current trends in paediatric infections in the Russian Federation by Yu. V. Lobzin, S. V. Rychkova, A. N. Uskov, N. V. Skripchenko, V. V. Fedorov
Published 2020-08-01
Article -
15
-
16
-
17
-
18
Сost-effectiveness of the second wave of protease inhibitors in the treatment of chronic hepatitis C (genotype 1) in patients not previously treated with antiviral drugs, and for r... by A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2016-04-01
Article -
19
-
20